Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Collaboration with Pierre Fabre increases Merck's focus...
Warning on risks of leading cancer drug sends Genentech...
Agilent Technologies acquires Silicon Genetics and...
Merck finds that its COX 2 inhibitor more dangerous than...
The bad news keeps on coming, better move out the way....
Move over statins, cancer drug lowers cholesterol. More...
Complex deal with Bayer increase sales force, but -...
For the past week and a half the news hasn t been good,...
Pfizer's Second COX-2 Inhibitor Gets Warning. More...
The $25B pain market is in trouble, but new technologies...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here